PRECISION BIOSCIENCES INC Income Tax Expense
PRECISION BIOSCIENCES INC (DTIL) reported Income Tax Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-03-12
- PRECISION BIOSCIENCES INC income tax expense (benefit) for the quarter ending 2019-03-31 was $0.00.
- PRECISION BIOSCIENCES INC income tax expense (benefit) for the quarter ending 2018-03-31 was $0.00.
- PRECISION BIOSCIENCES INC income tax expense (benefit) for fiscal 2025 was $0.00.
- PRECISION BIOSCIENCES INC income tax expense (benefit) for fiscal 2024 was $0.00.
- PRECISION BIOSCIENCES INC income tax expense (benefit) for fiscal 2020 was $23.00K.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-12 | |
| 2020-12-31 | $23.00K 10-K · filed 2022-03-15 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-04-29 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |